Blue Bird Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Blue Bird Tbk trades at Rp1,575 (market cap 3.89T, 574.8K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 310.75B, 159.2K 24h volume). The key difference: Blue Bird Tbk is far larger — about 12.5× Diagnos Laboratorium Utama Tbk.'s market cap, and Blue Bird Tbk is more actively traded (574.8K versus 159.2K). Which is the better fit depends on your goals.
| BIRD | DGNS | |
|---|---|---|
Market Cap | 3.89T | 310.75B |
Volume | 574.8K | 159.2K |
Lot | 5.75K | 1.59K |
Turnover | 903.2M | 34.72M |
Average Price | 1,571.32 | 218.06 |
Value | 903.2M | 34.72M |
Indicative Equilibrium Price | 1,575 | 220 |
Indicative Equilibrium Volume | 16 | 6 |
Trailing returns across standard periods
Latest headlines on both assets
PT Blue Bird Tbk (the Company) was established on March 29, 2001 based on Notarial Deed No. 11 of Dian Pertiwi, S.H.
Read more on BIRD →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →